Condition: Breast Cancer · Breast Reconstruction After Mastectomy · 3D-Printed Biodegradable Biological Mesh · Sponsor: Xijing Hospital
Primary objective of this trial: To evaluate the clinical performance (aesthetic outcome and quality of life) and safety of a 3D-printed biodegradable biological mesh in post-mastectomy immediate breast reconstruction. The study targets adult women undergoing total mastectomy for breast cancer followed by implant-based reconstruction. It aims to determine the utility of the 3D-printed biodegradable mesh in implant-based breast reconstruction, assess its influence on tissue regeneration, postoperative cosmetic result, and complication profile.
This description comes directly from the study's public registry record.
Ju Liang Zhang, Prof. · 029-84775271 · vascularzhang@163.com
Mei Ling Huang, MD · 029-84775271 · huangmeiling@126.com
Always discuss trial participation with your own doctor first.
| the First Affiliated Hospital of the Air Force Medical University | Xi'an, Shaanxi, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07365267